EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Mesenchymal stem cells for graft vs. host disease (CHU University Hospital Liege)

This trial aims to investigate the potential of mesenchymal stem cells (MSCs) in treating patients with steroid-refractory grade II-IV acute graft vs host disease (GVHD), poor graft function, or low or falling donor T-cell chimerism after allogeneic hematopoietic cell transplantation (HCT).

The cells were not characterized by the sponsor.
See additional Cell Therapies for: Blood , Lymph
Mesenchymal stem cells for graft vs. host disease (CHU University Hospital Liege)
Home
Contact Us
About Terms of Use Privacy Policy
Copyright LifeMap Sciences, Inc. - All Rights Reserved (v4.14 Build 1)
This site does not provide medical advice and is for research use only